Various ketogenic diet (KD) therapies, including classic KD, medium chain triglyceride administration, low glycemic index treatment, and a modified Atkins diet, have been suggested as useful in patients affected by pharmacoresistant epilepsy. A common goal of these approaches is to achieve an adequate decrease in the plasma glucose level combined with ketogenesis, in order to mimic the metabolic state of fasting. Although several metabolic hypotheses have been advanced to explain the anticonvulsant effect of KDs, including changes in the plasma levels of ketone bodies, polyunsaturated fatty acids, and brain pH, direct modulation of neurotransmitter release, especially purinergic (i.e., adenosine) and γ-aminobutyric acidergic neurotransmission, was also postulated. Neuropeptides and peptide hormones are potent modulators of synaptic activity, and their levels are regulated by metabolic states. This is the case for neuroactive peptides such as neuropeptide Y, galanin, cholecystokinin and peptide hormones such as leptin, adiponectin, and growth hormone-releasing peptides (GHRPs). In particular, the GHRP ghrelin and its related peptide des-acyl ghrelin are well-known controllers of energy homeostasis, food intake, and lipid metabolism. Notably, ghrelin has also been shown to regulate the neuronal excitability and epileptic activation of neuronal networks. Several lines of evidence suggest that GHRPs are upregulated in response to starvation and, particularly, in patients affected by anorexia and cachexia, all conditions in which also ketone bodies are upregulated. Moreover, starvation and anorexia nervosa are accompanied by changes in other peptide hormones such as adiponectin, which has received less attention. Adipocytokines such as adiponectin have also been involved in modulating epileptic activity. Thus, neuroactive peptides whose plasma levels and activity change in the presence of ketogenesis might be potential candidates for elucidating the neurohormonal mechanisms involved in the beneficial effects of KDs. In this review, we summarize the current evidence for altered regulation of the synthesis of neuropeptides and peripheral hormones in response to KDs, and we try to define a possible role for specific neuroactive peptides in mediating the antiepileptic properties of diet-induced ketogenesis.
Neuroactive Peptides as Putative Mediators of Antiepileptic Ketogenic Diets / GIORDANO, CARMELA; Maddalena, Marchiò; Elena, Timofeeva; BIAGINI, Giuseppe. - In: FRONTIERS IN NEUROLOGY. - ISSN 1664-2295. - ELETTRONICO. - 5 (63)(2014), pp. 1-14. [10.3389/fneur.2014.00063]
|Data di pubblicazione:||2014|
|Titolo:||Neuroactive Peptides as Putative Mediators of Antiepileptic Ketogenic Diets|
|Autore/i:||GIORDANO, CARMELA; Maddalena, Marchiò; Elena, Timofeeva; BIAGINI, Giuseppe|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.3389/fneur.2014.00063|
|Codice identificativo ISI:||WOS:000209629300063|
|Codice identificativo Scopus:||2-s2.0-84901008236|
|Codice identificativo Pubmed:||24808888|
|Citazione:||Neuroactive Peptides as Putative Mediators of Antiepileptic Ketogenic Diets / GIORDANO, CARMELA; Maddalena, Marchiò; Elena, Timofeeva; BIAGINI, Giuseppe. - In: FRONTIERS IN NEUROLOGY. - ISSN 1664-2295. - ELETTRONICO. - 5 (63)(2014), pp. 1-14. [10.3389/fneur.2014.00063]|
|Tipologia||Articolo su rivista|
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris